Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3137Triple Negative Breast Neoplasms 513Ovarian Neoplasms 226Colorectal Neoplasms 191Carcinoma, Non-Small-Cell Lung 190Prostatic Neoplasms 183Neoplasms 176Lung Neoplasms 164Neoplasm Metastasis 162Melanoma 118Stomach Neoplasms 114Pancreatic Neoplasms 112Endometrial Neoplasms 106Uterine Cervical Neoplasms 93Squamous Cell Carcinoma of Head and Neck 88Carcinoma, Intraductal, Noninfiltrating 82Head and Neck Neoplasms 81Colonic Neoplasms 81Sarcoma 63Breast Carcinoma In Situ 62Urinary Bladder Neoplasms 60Carcinoma, Renal Cell 60Motor Activity 59Esophageal Neoplasms 58Brain Neoplasms 50Lymphedema 44Breast Cancer Female 41Advanced Breast Cancer 40Liver Neoplasms 39HER2-positive Breast Cancer 38

Interventions

eribulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ketosis × Breast × 1 year × Clear all
NCT02061085 2025-06-08

MERIBEL

MedSIR

Phase 2 Completed
53 enrolled 11 charts
Breast

Breast Neoplasms, Ketosis, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡